These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 22556352)

  • 1. Nuclear factor-κB dysregulation in splenic marginal zone lymphoma: new therapeutic opportunities.
    Arcaini L; Rossi D
    Haematologica; 2012 May; 97(5):638-40. PubMed ID: 22556352
    [No Abstract]   [Full Text] [Related]  

  • 2. BCR and TLR signaling pathways are recurrently targeted by genetic changes in splenic marginal zone lymphomas.
    Yan Q; Huang Y; Watkins AJ; Kocialkowski S; Zeng N; Hamoudi RA; Isaacson PG; de Leval L; Wotherspoon A; Du MQ
    Haematologica; 2012 Apr; 97(4):595-8. PubMed ID: 22102703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NF-κB deregulation in splenic marginal zone lymphoma.
    Spina V; Rossi D
    Semin Cancer Biol; 2016 Aug; 39():61-7. PubMed ID: 27503810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA expression profile in splenic marginal zone lymphoma.
    Bouteloup M; Verney A; Rachinel N; Callet-Bauchu E; Ffrench M; Coiffier B; Magaud JP; Berger F; Salles GA; Traverse-Glehen A
    Br J Haematol; 2012 Jan; 156(2):279-81. PubMed ID: 21902683
    [No Abstract]   [Full Text] [Related]  

  • 5. Toll-like receptor stimulation in splenic marginal zone lymphoma can modulate cell signaling, activation and proliferation.
    Fonte E; Agathangelidis A; Reverberi D; Ntoufa S; Scarfò L; Ranghetti P; Cutrona G; Tedeschi A; Xochelli A; Caligaris-Cappio F; Ponzoni M; Belessi C; Davis Z; Piris MA; Oscier D; Ghia P; Stamatopoulos K; Muzio M
    Haematologica; 2015 Nov; 100(11):1460-8. PubMed ID: 26294727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular pathogenesis of splenic and nodal marginal zone lymphoma.
    Spina V; Rossi D
    Best Pract Res Clin Haematol; 2017; 30(1-2):5-12. PubMed ID: 28288716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD5 expression identifies a subset of splenic marginal zone lymphomas with higher lymphocytosis: a clinico-pathological, cytogenetic and molecular study of 24 cases.
    Baseggio L; Traverse-Glehen A; Petinataud F; Callet-Bauchu E; Berger F; Ffrench M; Couris CM; Thieblemont C; Morel D; Coiffier B; Salles G; Felman P
    Haematologica; 2010 Apr; 95(4):604-12. PubMed ID: 20015887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emu-BCL10 mice exhibit constitutive activation of both canonical and noncanonical NF-kappaB pathways generating marginal zone (MZ) B-cell expansion as a precursor to splenic MZ lymphoma.
    Li Z; Wang H; Xue L; Shin DM; Roopenian D; Xu W; Qi CF; Sangster MY; Orihuela CJ; Tuomanen E; Rehg JE; Cui X; Zhang Q; Morse HC; Morris SW
    Blood; 2009 Nov; 114(19):4158-68. PubMed ID: 19696203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved biological insight and influence on management in indolent lymphoma. Talk 3: update on nodal and splenic marginal zone lymphoma.
    Thieblemont C
    Hematology Am Soc Hematol Educ Program; 2017 Dec; 2017(1):371-378. PubMed ID: 29222281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Higher expression levels of activation-induced cytidine deaminase distinguish hairy cell leukemia from hairy cell leukemia-variant and splenic marginal zone lymphoma.
    Hockley SL; Morilla A; Else M; Dearden C; Catovsky D; Morgan GJ; Matutes E; Gonzalez D
    Leukemia; 2010 May; 24(5):1084-6. PubMed ID: 20237507
    [No Abstract]   [Full Text] [Related]  

  • 11. FOXP1 status in splenic marginal zone lymphoma: a fluorescence in situ hybridization and immunohistochemistry approach.
    Baró C; Espinet B; Salido M; Colomo L; Luño E; Florensa L; Ferrer A; Salar A; Campo E; Serrano S; Solé F
    Histol Histopathol; 2009 Nov; 24(11):1399-404. PubMed ID: 19760589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methylation patterns in marginal zone lymphoma.
    Arribas AJ; Bertoni F
    Best Pract Res Clin Haematol; 2017; 30(1-2):24-31. PubMed ID: 28288713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Splenic B-cell lymphomas with more than 55% prolymphocytes in blood: evidence for prolymphocytoid transformation.
    Hoehn D; Miranda RN; Kanagal-Shamanna R; Lin P; Medeiros LJ
    Hum Pathol; 2012 Nov; 43(11):1828-38. PubMed ID: 22520947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Whole-exome sequencing in splenic marginal zone lymphoma reveals mutations in genes involved in marginal zone differentiation.
    Martínez N; Almaraz C; Vaqué JP; Varela I; Derdak S; Beltran S; Mollejo M; Campos-Martin Y; Agueda L; Rinaldi A; Kwee I; Gut M; Blanc J; Oscier D; Strefford JC; Martinez-Lopez J; Salar A; Sole F; Rodriguez-Peralto JL; Diez-Tascón C; García JF; Fraga M; Sebastián E; Alvés J; Menárguez J; González-Carreró J; Casado LF; Bayes M; Bertoni F; Gut I; Piris MA
    Leukemia; 2014 Jun; 28(6):1334-40. PubMed ID: 24296945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Splenic marginal zone lymphoma.
    Piris MA; Onaindía A; Mollejo M
    Best Pract Res Clin Haematol; 2017; 30(1-2):56-64. PubMed ID: 28288718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Advances in molecular genetics pathogenesis of splenic marginal zone lymphoma].
    Yan Y; Yi S; Qiu L
    Zhonghua Xue Ye Xue Za Zhi; 2016 Apr; 37(4):348-52. PubMed ID: 27094004
    [No Abstract]   [Full Text] [Related]  

  • 17. MicroRNA losses in the frequently deleted region of 7q in SMZL.
    Ruiz-Ballesteros E; Mollejo M; Mateo M; Algara P; Martínez P; Piris MA
    Leukemia; 2007 Dec; 21(12):2547-9. PubMed ID: 17625607
    [No Abstract]   [Full Text] [Related]  

  • 18. Alteration of BIRC3 and multiple other NF-κB pathway genes in splenic marginal zone lymphoma.
    Rossi D; Deaglio S; Dominguez-Sola D; Rasi S; Vaisitti T; Agostinelli C; Spina V; Bruscaggin A; Monti S; Cerri M; Cresta S; Fangazio M; Arcaini L; Lucioni M; Marasca R; Thieblemont C; Capello D; Facchetti F; Kwee I; Pileri SA; Foà R; Bertoni F; Dalla-Favera R; Pasqualucci L; Gaidano G
    Blood; 2011 Nov; 118(18):4930-4. PubMed ID: 21881048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selection of antigen receptors in splenic marginal-zone lymphoma: further support from the analysis of the immunoglobulin light-chain gene repertoire.
    Bikos V; Stalika E; Baliakas P; Darzentas N; Davis Z; Traverse-Glehen A; Dagklis A; Kanellis G; Anagnostopoulos A; Tsaftaris A; Ponzoni M; Berger F; Felman P; Ghia P; Papadaki T; Oscier D; Belessi C; Stamatopoulos K
    Leukemia; 2012 Dec; 26(12):2567-9. PubMed ID: 22858907
    [No Abstract]   [Full Text] [Related]  

  • 20. Bone marrow histopathology in the diagnostic evaluation of splenic marginal-zone and splenic diffuse red pulp small B-cell lymphoma: a reliable substitute for spleen histopathology?
    Ponzoni M; Kanellis G; Pouliou E; Baliakas P; Scarfò L; Ferreri AJ; Doglioni C; Bikos V; Dagklis A; Anagnostopoulos A; Ghia P; Stamatopoulos K; Papadaki T
    Am J Surg Pathol; 2012 Nov; 36(11):1609-18. PubMed ID: 23073320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.